30 postmenopausal or oophorectomised women with metastasising breast cancer were treated with cyclophosphamide 500 mg weekly or with triethylenthiophosphoramide 20 mg monthly; aminopterin, fluorouracil or vinblastine were given in association. A marked reduction of the metastases was observed in 15 of the 30 cases treated.
Get full access to this article
View all access options for this article.
References
1.
Gruppo di Studio per la Terapia del Carcinoma Mammario:Confronto fra i risultati ottenuti con terapia androgena e terapia con androgeni e cistostatici nel carcinoma mammario avanzato.Tumori, 54: 333–344, 1968.
2.
KennedyB. J., and BrownJ. H.: Combined estrogenic and androgenic hormone therapy in advanced breast cancer.Cancer, 18: 431, 1965.
